Rare diseases
Investigational molecules
Locations
Ul. Zygmunta Krasinskiego 54/56, 01-755 Warsaw, Poland
Wojskowy Instytut Medycyny Lotniczej in Warsaw, Poland specialises in clinical trials of conditions such as Huntington's disease, Epilepsy, Secondary progressive multiple sclerosis, Tuberous sclerosis complex, and other specialisations. This site conducts important research.
The medical center is at the forefront of research in neurodegenerative diseases, with a particular focus on Huntington's Disease. This condition, characterized by the progressive degeneration of nerve cells in the brain, is a key area of study.
Through innovative research, the center is advancing the understanding of disease mechanisms and developing potential therapeutic interventions, such as the evaluation of tominersen for its safety and efficacy in altering disease progression.
Clinical trials currently enrolling participants at this site.
Efficacy and safety of votoplam in adults with Huntington’s disease: a randomized, double‑blind, placebo‑controlled Phase 3 trial
PolandStudy on the Effectiveness and Safety of Sirolimus for Patients with Drug-Resistant Epilepsy Linked to Tuberous Sclerosis Complex
PolandPhase 3 Study of Pridopidine Hydrochloride for Safety and Efficacy in Adults with Huntington’s Disease
PolandStudy on Cladribine for Treating Secondary Progressive Multiple Sclerosis in Patients with Recent Progression and No Recent Relapses
PolandStudy on the Safety and Effects of AMT-130 for Adults with Early Huntington's Disease
PolandStudy on the Safety and Efficacy of Tominersen for Patients with Prodromal and Early Manifest Huntington's Disease
PolandGet verified: confirm your contact details and recruitment status with us, appear first on the pages of your trials and receive patient requests directly.
See the offer for sitesTell us about your condition – we search every trial in Europe and connect you with the right site.
